CST2
Basic information
Region (hg38): 20:23823769-23826729
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CST2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 3 | 1 |
Variants in CST2
This is a list of pathogenic ClinVar variants found in the CST2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-23824054-A-C | not specified | Uncertain significance (Jul 13, 2021) | ||
20-23824058-T-C | not specified | Uncertain significance (Jun 13, 2024) | ||
20-23824061-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
20-23824076-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
20-23824085-G-C | not specified | Uncertain significance (Sep 01, 2021) | ||
20-23824094-A-T | not specified | Uncertain significance (Jun 19, 2024) | ||
20-23825214-T-C | not specified | Uncertain significance (Oct 20, 2021) | ||
20-23825226-T-G | not specified | Uncertain significance (Jun 23, 2023) | ||
20-23825235-A-G | not specified | Uncertain significance (Oct 13, 2023) | ||
20-23825271-C-T | not specified | Uncertain significance (Aug 11, 2024) | ||
20-23825274-A-G | not specified | Likely benign (Aug 14, 2024) | ||
20-23825296-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
20-23825304-T-G | not specified | Uncertain significance (Dec 15, 2023) | ||
20-23825320-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
20-23825322-A-G | not specified | Likely benign (Oct 20, 2024) | ||
20-23825326-A-G | Likely benign (Feb 09, 2018) | |||
20-23826446-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
20-23826456-G-A | Benign (Feb 09, 2018) | |||
20-23826478-A-T | not specified | Uncertain significance (Dec 12, 2023) | ||
20-23826488-G-A | not specified | Uncertain significance (May 25, 2022) | ||
20-23826491-T-C | not specified | Uncertain significance (Jun 10, 2024) | ||
20-23826501-C-T | not specified | Uncertain significance (May 30, 2023) | ||
20-23826512-A-C | not specified | Uncertain significance (Mar 08, 2025) | ||
20-23826524-C-T | not specified | Uncertain significance (Jun 13, 2024) | ||
20-23826528-G-T | not specified | Uncertain significance (Jun 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CST2 | protein_coding | protein_coding | ENST00000304725 | 3 | 2963 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.06e-8 | 0.0467 | 125028 | 8 | 712 | 125748 | 0.00287 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -2.12 | 135 | 81.2 | 1.66 | 0.00000455 | 903 |
Missense in Polyphen | 35 | 19.964 | 1.7531 | 231 | ||
Synonymous | -3.53 | 60 | 33.9 | 1.77 | 0.00000184 | 275 |
Loss of Function | -1.25 | 9 | 5.76 | 1.56 | 3.44e-7 | 56 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0384 | 0.0382 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000599 | 0.000598 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000158 | 0.000158 |
Middle Eastern | 0.000599 | 0.000598 |
South Asian | 0.00140 | 0.00141 |
Other | 0.000815 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Thiol protease inhibitor.;
- Pathway
- Salivary secretion - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- loftool
- 0.867
- rvis_EVS
- 0.97
- rvis_percentile_EVS
- 90.34
Haploinsufficiency Scores
- pHI
- 0.0806
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.175
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- detection of chemical stimulus involved in sensory perception of bitter taste;negative regulation of endopeptidase activity
- Cellular component
- extracellular space
- Molecular function
- cysteine-type endopeptidase inhibitor activity;protein binding